With QUiCKR, accelerate programs
in R&D, IND, and Process Development
5X faster while saving 70% on NGS costs
in R&D, IND, and Process Development
5X faster while saving 70% on NGS costs
120x Faster Results
Turnaround Time
5 Days
20 min
3x Throughput per Reader
Samples/day
400
1500
3x Reduction in Genomics Spend
Cost/Sample (with FTEs)
$50
$15
72x Reduction in Hands-On Time
Hands-on Time for 96 samples
12 Hours
10 min
NGS
QUiCKR
QUiCKR V2
20 min sample-to-results
High-Throughput
20-150 samples / plate
Automated
0 new instruments required
30,000+ reactions analyzed to date
QUiCKR Workflow
Quantification Using initial CRISPR Kinetic Rates
User Edited Sample
Sample Prep
Plate Transfer
Fluorescent
Readout
Cloud-based
Instant Results
Meet Our Team
We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.
Charles Blanluet
CEO & Cofounder
Stanford Microfludics, Guardant
Prof. Juan Santiago
Scientific Cofounder
Stanford Microfludics, Purigen Biosystems
Jiawei Lee
CBO & Cofounder
UC Berkeley & UCSF, Sequoia
Henrik Sperber
CTO & Cofounder
CRISPR Therapeutics, Paratus Sciences
Prof. Matthew Porteus
Scientific Advisor
Stanford Medicine, CRISPR Therapeutics
Hari Jayaram
Scientific Advisor
Verve Therapeutics, Editas Medicine, Arena BioWorks
Sepehr Kiani